Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

l items (Adjusted EBITDA).  Beginning in 2011, the non-GAAP Adjusted EBITDA measure rather than the prior non-GAAP income will be utilized in discussing financial performance as this metric is more aligned with management's internal goal setting process.The following tables detail the reconciliation of non-GAAP to GAAP financial metrics:

Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income For the Three and Twelve Months Ended December 31, 2010 and 2009(in millions)(unaudited) Three Months Ended
December 31,Years Ended
December 31,NOTES2010200920102009GAAP Net Income (Loss)$ (12.2)$   4.7$ 205.8$ (0.5)Stock-based compensation expense9.88.837.534.5Upfront license fees

(1)---8.8Impairment charges

(2)---5.9Net gain on the sale of equity investments--(0.9)(1.6)Debt conversion expense

(3)13.7-13.7-Acquisition expenses

(4)--1.8-Tax benefit

(5)--(223.1)-Non-GAAP Net Income$  11.3$ 13.5$   34.8$ 47.1(1)  Represents upfront license payments related to our collaboration agreement with La Jolla Pharmaceutical Company in the first quarter of 2009.   (2)  Includes impairment losses on investments in Summit plc. and La Jolla Pharmaceutical Company recognized during the first quarter of 2009.(3)   Represents debt conversion expense associated with the early conversion of a portion our convertible debt in November 2010.(4)   Represents transactions costs associated with the acquisition of ZyStor Therapeutics Inc., during the third quarter of 2010.   (5)  Represents only the portion of total tax expense for the period related to the reversal of the Company's income tax valuation allowance during the third quarter of 2010.Reconciliation of GAAP Net Income (Loss) to EBITDA and Adjusted EBITDAFor the Year Ended December 31, 2010 with Guidance for 2011(in millions)(unaudited) NOTESYear EndedDecember 31, 2010Year Ending
December 31, 2011GuidanceGA
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a ... use in portable vaporizers, which contains CBD, or ... cannabis, cannabidiol offers consumers a THC-free product made ... vaporizer technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... different compounds which are currently known, two of ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... the "Global and Chinese Medical X-ray Film Industry ... http://photos.prnewswire.com/prnh/20130307/600769 Global And ... professional and in-depth study on the current state of ... on the Chinese situation. The report provides a ...
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery ... that it has raised A$19.3 million via a placement ... Europe , the U.S., Asia ... million from a share purchase plan (SPP) to be ... will be made in two tranches. "This ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2Global and Chinese Medical X-ray Film Industry Report 2014 2Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3
... NANJING , China , April 21 ... SCR ), a leading pharmaceutical company,specializing in ... pharmaceuticals in China , today announced that its,diosmectite, ... Biqi, has passed EU-GMP inspection. This enables Simcere to,market ...
... , April 21 PharmaMar, a biopharmaceutical company ... drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research,s ... April 17-21 . , , ... AACR meeting is the leading convention on cancer research, bringing together more ...
Cached Medicine Technology:Simcere's Diosmectite API Passes EU-GMP Inspection 2PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 2PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 3
(Date:7/13/2014)... New York, New York (PRWEB) July 13, 2014 ... mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against ... the litigation’s second bellwether trial, which is expected to ... Control Order issued in the U.S. District Court, Southern ... Pretrial Conference will be held on August 7, 2014 ...
(Date:7/13/2014)... Rico (PRWEB) July 13, 2014 ... of Famer, Chris Mullin, will be the featured guest ... July 26th in Puerto Rico. Attendees will learn ... will participate in two exhibition basketball games and perform ... ultimate supplier of health- and energy-boosting supplements , ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Fadhits.com is ... sexy prom dresses are extremely beautiful. Recently, the company ... dresses for 2014. What’s more, all these outfits ... percent off). , Additionally, the supplier is now ... with elegant Quinceanera dresses, it has many other designs ...
(Date:7/13/2014)... noninvasive optical imaging device developed at Cedars-Sinai can ... in the brain and are a classic sign ... investigators conducting a clinical trial in Australia. , ... in an oral presentation at the Alzheimer,s Association ... were invited by conference organizers to participate in ...
(Date:7/13/2014)... According to the Kidney Disease Solution book review recently ... on what to do to eliminate the root cause ... its review that readers can easily learn what foods to ... health. Vkool also informs in its Kidney Disease Solution review ... functions naturally. The book consists of a collection of natural ...
Breaking Medicine News(10 mins):Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3
... Pinnacle health systems already achieving positive results following ... April 3 CentraState and Pinnacle health ... information technology to improve nursing practice as part ... www.siemens.com/healthcare ) experience at ...
... and Distribution Workflow Solution Provides Final Reports in ... UltraRAD Corp. and StructuRad LLC announce that ... now in production at Valor Network, Inc. The ... image management and reporting based on StructuRad,s StudyManager ...
... Foods to Donate $250,000 - 1.75 million meals ... Relief OrganizationOMAHA, Neb., April 3 Healthy Choice, ... completely reinvented - focusing on what people want ... for the frozen entree category. After 20 years ...
... Calif., April 3 IDM Pharma, Inc. (Nasdaq: ... of innovative cancer products, including MEPACT(R) (known as mifamurtide ... Europe for the treatment of osteosarcoma, today announced that ... 31, 2008, included in the Annual Report on Form ...
... Betsy Vasquez, MD announced today the opening of AVIE!, their new medical ... Plaza II. , ... Leesburg, VA (PRWEB) April 3, 2009-- Kim ... and Laser Center is officially open for business at their Fort Evans ...
... 2 As news emerged that Gov. Kathleen ... has been postponed until the end of April, ... Brownback and Pat Roberts to reject the nomination.(Logo: ... on "Senatorial Courtesy" -- the longstanding Senate tradition ...
Cached Medicine News:Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 2Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 3Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 4Health News:UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster 2Health News:UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster 3Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 2Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 3Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 4Health News:IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fiscal Year Containing Audit Opinion With Going Concern Qualification 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 3Health News:A.L.L. Calls on KS Senators to Stop Sebelius as Confirmation Postponed 2
... dermal matrix derived from donated human skin ... utilizing the standards of the American Association ... Drug Administration's (FDA) guidelines. Since AlloDerm is ... changed in structure from the natural material, ...
... a sterile off white, moist, tough but ... and its constituent elastin fibres presented moist ... ready to use in double vacuum packed ... oxygen, and is sterilised by gamma irradiation. ...
... TONO-PEN AVIA tonometer is an easy-to-use, ... that correlate strongly with Goldmann tonometry. ... design and advanced electronic measurement technology ... and accurate IOP measurements with minimal ...
... The Invisio Digital Flexible Ureteroscope ... features from the proven durable, market ... is also the first device utilizing ... 1 mm Complementary Metal Oxide Semi-Conductor ...
Medicine Products: